Patents Assigned to CK BIOTECH
  • Publication number: 20240425457
    Abstract: Therapeutic compositions comprising one or more agents that inhibit CXXC5-DVL interface, and methods of administering those therapeutic compositions to model, treat, reduce resistance to treatment, prevent, and diagnose a condition/disease associated with a metabolic disease or a related clinical condition thereof, are disclosed.
    Type: Application
    Filed: August 6, 2024
    Publication date: December 26, 2024
    Applicant: CK Biotech Inc.
    Inventors: Kang-Yell Choi, Seol Hwa Seo, Eunhwan Kim
  • Publication number: 20230105449
    Abstract: The present disclosure relates to a composition for preventing or treating wound. The composition according to the present disclosure contains, as an active ingredient, an indirubin derivative alone or one or more selected from a group consisting of an indirubin derivative, an Euodia sutchuenensis Dode extract, methyl vanillate, hesperidin and quercitrin, and thus can be used as a pharmaceutical composition capable of promoting wound healing and reducing scarring not only in a normal state but also in a diabetic state. Furthermore, since the composition exhibits excellent effects in healing diabetic wound as well as general wound, it can be usefully used as a pharmaceutical composition, cosmetic composition or food composition for alleviating, preventing or treating general wound or diabetic wound, or as a veterinary composition for treating diabetic wound.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 6, 2023
    Applicant: CK BIOTECH
    Inventors: Kang-Yell CHOI, Eunhwan KIM, Seol Hwa SEO, Minguen YOON
  • Patent number: 11154566
    Abstract: The present invention is about composition for preventing hair loss or promoting hair growth comprising indirubin derivatives; and one or more selected from the group consisting of Euodia daniellii extract, Persicaria hydropiper extract, Hovenia dulcis extract, methyl vanillate, hesperidin and quercitrin; as an active ingredient. In addition, one or more selected from the group consisting of Euodia daniellii extract, Persicaria hydropiper extract, Hovenia dulcis extract, methyl vanillate, hesperidin and quercitrin of the present invention is a natural-derived composition with little toxicity to cells. Indirubin derivatives are stable compounds that have been found to have little toxicity to the human body, and therefore, when used in a mixture thereof, there are advantages in that they do not exhibit adverse effects on the human body, unlike conventional steroid drugs.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: October 26, 2021
    Assignee: CK BIOTECH
    Inventors: Kang-Yell Choi, Jiyong Shim, Yeong Chan Ryu, Jiyeon Park
  • Publication number: 20210261529
    Abstract: The present disclosure relates to a composition for preventing or treating wound. The composition according to the present disclosure contains, as an active ingredient, an indirubin derivative alone or one or more selected from a group consisting of an indirubin derivative, an Euodia sutchuenensis Dode extract, methyl vanillate, hesperidin and quercitrin, and thus can be used as a pharmaceutical composition capable of promoting wound healing and reducing scarring not only in a normal state but also in a diabetic state. Furthermore, since the composition exhibits excellent effects in healing diabetic wound as well as general wound, it can be usefully used as a pharmaceutical composition, cosmetic composition or food composition for alleviating, preventing or treating general wound or diabetic wound, or as a veterinary composition for treating diabetic wound.
    Type: Application
    Filed: July 4, 2019
    Publication date: August 26, 2021
    Applicant: CK BIOTECH
    Inventors: Kang-Yell CHOI, Eunhwan KIM, Seol Hwa SEO, Minguen YOON
  • Publication number: 20200179425
    Abstract: The present invention is about composition for preventing hair loss or promoting hair growth comprising indirubin derivatives; and one or more selected from the group consisting of Euodia daniellii extract, Persicaria hydropiper extract, Hovenia dulcis extract, methyl vanillate, hesperidin and quercitrin; as an active ingredient. In addition, one or more selected from the group consisting of Euodia daniellii extract, Persicaria hydropiper extract, Hovenia dulcis extract, methyl vanillate, hesperidin and quercitrin of the present invention is a natural-derived composition with little toxicity to cells. Indirubin derivatives are stable compounds that have been found to have little toxicity to the human body, and therefore, when used in a mixture thereof, there are advantages in that they do not exhibit adverse effects on the human body, unlike conventional steroid drugs.
    Type: Application
    Filed: July 31, 2018
    Publication date: June 11, 2020
    Applicant: CK BIOTECH
    Inventors: Kang-Yell CHOI, Jiyong SHIM, Yeong Chan RYU, Jiyeon PARK